Aspire Night Cold and Flu Softgel

Product NDC
81013-102
11-digit product format
810130102
Labeler code
81013
Product ID
81013-102_f1f406b0-c983-63ab-e053-2a95a90ad8c3
Type
HUMAN OTC DRUG
Nonproprietary name
Aspire Night Cold and Flu Softgel
Dosage form
CAPSULE, LIQUID FILLED
Route
ORAL
Labeler
Aspire Pharmaceuticals Inc.
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2021-03-17
Marketing end
0000-00-00
Substance
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE
Active strength
325 mg/1; mg/1; mg/1; mg/1
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2024-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
81013-102-012025-01-30C16284748780-12cef2736-8269-d83d-e063-dadaa90ab31fb3397e24-4cda-ac0a-e053-2a95a90afae2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
81013-102-01810130102015000 CAPSULE, LIQUID FILLED in 1 BAG (81013-102-01) 2021-03-170000-00-00NoNoCurrent